Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Ross S Firestone

16PUBLICATIONS

67CO-AUTHORS

Haematological tumoursPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical mycologyNuclear and plasma physics not elsewhere classified

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (16)

Sort by Publication Date:

|May 01, 2026

A differentiated effector T cell repertoire defines a functionally high-risk group of smoldering myeloma patients.

|Apr 12, 2026

Functionally high-risk disease is associated with poor outcomes after late-line CAR T-cell therapy for multiple myeloma.

Hamza Hashmi, Tara Sebastian, Sridevi Rajeeve

|Feb 17, 2026

IMS-IMWG 2025 consensus genomic staging predicts outcomes with daratumumab-based quadruplet regimens for NDMM.

Kylee H Maclachlan, Carlyn Rose Tan, Tala Shekarkhand

|Nov 02, 2025

Cytomegalovirus reactivation during treatment with bispecific antibodies for relapsed/refractory multiple myeloma.

Eric Jurgens, Tala Shekarkhand, Colin Rueda

|Oct 08, 2025

Genomics Define Malignant Transformation in Myeloma Precursor Conditions.

Francesco Maura, P Leif Bergsagel, Bachisio Ziccheddu

|Aug 25, 2025

Immune MRD Status Informs Tumor MRD Outcome Prognostication in Patients with Multiple Myeloma on Lenalidomide Maintenance.

Ross S Firestone, Anish K Simhal, Devin McAvoy

Pageof 3

Frequent Collaborators

14 joint publications

Malin L Hultcrantz

13 joint publications

Kylee Maclachlan

12 joint publications

Urvi Shah

11 joint publications

Alexander M Lesokhin

11 joint publications

Carlyn Tan

11 joint publications

Sergio Giralt

11 joint publications

Heather J Landau

10 joint publications

Neha Korde

8 joint publications

Saad Z Usmani

8 joint publications

Gunjan L Shah

Frequent Collaborators

14 joint publications

Malin L Hultcrantz

13 joint publications

Kylee Maclachlan

12 joint publications

Urvi Shah

11 joint publications

Alexander M Lesokhin

Top Related Videos

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on : Mar 30, 2018

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [<sup>18</sup>F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [<sup>18</sup>F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on : Feb 17, 2022

Interphase Fluorescence <em>in situ</em> Hybridization of Bone Marrow Smears of Multiple Myeloma

Interphase Fluorescence <em>in situ</em> Hybridization of Bone Marrow Smears of Multiple Myeloma

Published on : Apr 15, 2022

See more related videos

Top Related Videos

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on : Mar 30, 2018

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [<sup>18</sup>F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [<sup>18</sup>F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on : Feb 17, 2022

Interphase Fluorescence <em>in situ</em> Hybridization of Bone Marrow Smears of Multiple Myeloma

Interphase Fluorescence <em>in situ</em> Hybridization of Bone Marrow Smears of Multiple Myeloma

Published on : Apr 15, 2022

See more related videos